In this paper, we numerically show that the dynamics of the HIV system is sensitive to both the initial condition and the system parameters. These phenomena imply that the system is chaotic and exhibits a bifurcation behavior. To control the system, we propose to initiate an HIV therapy based on both the concentration of the HIV-1 viral load and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population. If the concentration of the HIV-1 viral load is higher than a threshold, then the first type of therapy will be applied. If the concentration of the HIV-1 viral load is lower than or equal to the threshold and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population is greater than another threshold, then the second type of therapy will be applied.
I. INTRODUCTION
In 2005, there were about 38.6 millions of adults and children suffering from the human immunodeficiency virus (HIV). The total infected population is increasing year by year [8] . There are about twenty medications approved by the Food and Drug Administration (FDA) of the US government. These medications can suppress the acquired immune deficiency syndrome (AIDS).
It was reported in [9] - [27] that the response of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 viral load can be characterized by a first order nonlinear differential equation. In this paper, we numerically show that the system dynamics is sensitive to both the initial condition and the system parameters. This implies that the system is chaotic and exhibits a bifurcation behavior. Moreover, the concentrations of the CD4 lymphocyte population, the CD8 lymphocyte population, the HIV-1 viral load and the dose are required to be non-negative and bounded, this implies that the positivity constraint of the system states and that of the dose concentration is required to be satisfied [5] . Because of the chaotic nature of the system and the positivity constraint, the system is very difficult to be controlled. Furthermore, the system has two equilibrium points and one of them is unstable [1] . This implies that a very small derivation of the system vectors from the equilibrium point would cause the system trajectory to diverge locally. In order to control the concentration of the HIV-1 viral load being exactly equal to zero within a certain period of time, zero boundary conditions of the controlled system are required to be satisfied.
However, it was reported in [7] that the corresponding linearized system (linearized at the unstable equilibrium point) is uncontrollable, so linear control methods would usually result to the loss of control near the equilibrium point.
The simplest existing strategy for controlling the HIV-1 viral load is via the P control law [1] , [2] , [4] , that is the dose concentration is directly proportional to the concentration of the HIV-1 viral load. However, this control strategy fails to satisfy the positivity constraint and in general this control method does not guarantee the asymptotical stability of the system. Optimal control methods [3] , [6] are also proposed. However, all these control methods are derived based on the corresponding International Journal of Bifurcation and Chaos 3 linearized model, in which the system will lose control when the trajectory is close to the equilibrium point [7] .
As the medications have strong side effects, medical professions would prefer to initiate the therapy only at certain situations [7] . However, there is no standard rule for the determination of the time instant that the therapy initiates. Also, the corresponding dose concentration is unknown. In this paper, we propose to initiate the therapy based on both the concentration of the HIV-1 viral load and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population. If the concentration of the HIV-1 viral load is higher than a threshold, then the first type of therapy will be applied. If the concentration of the HIV-1 viral load is lower than or equal to the threshold and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population is greater than another threshold, then the second type of therapy will be applied. Otherwise, no therapy will be applied. The advantages of the proposed control strategy are that the therapy can be stopped under certain conditions, while the state variables of the overall system is asymptotically stable with fast convergent rate, the concentration of the controlled HIV-1 viral load is monotonic decreasing, as well as the positivity constraint of the system states and that of the dose concentration is guaranteed to be satisfied.
The outline of this paper is as follows: The HIV model is reviewed in Section II. In Section III, the sensitivity of the initial condition and the system parameters against the system dynamics is simulated. The obtained results imply that the system is chaotic and exhibits a bifurcation behavior. In Section IV, a control strategy is proposed. Computer numerical simulation results are also presented.
Finally, a conclusion is drawn in Section V. Figure 1a shows the state responses of the system, while Figure 1b shows the corresponding state trajectory, in which 25
II. HIV MODEL

SYSTEM DYNAMICS
. It can be seen from Figure 1b that the system exhibits a complex behavior. Figure 2 plots the Lyapunov exponents of the system at different time instants with the system parameters being the same as that applied in Figure 1 and with the initial condition being the state vectors at the corresponding time instants. It can be seen from Figure 2 that the Lyapunov exponent of ( ) 
. Similarly, Figure 5 to Figure 9 plot the corresponding ranges as the parameter b to the parameter f vary, respectively. From these computer numerical simulation results, we can see that the parameters d
and e are the most sensitive to the system dynamics. Hence, we can conclude that the system is chaotic and exhibits a bifurcation phenomenon. This chaotic nature of the system causes the formulation of the control strategy being very challenging.
IV. PROPOSED CONTROL STRATEGY
Denote ( ) t U as the dose concentration. This corresponds to the control force of the system.
Consider the following control force
and define International Journal of Bifurcation and Chaos
It can be easily seen that ( ) 0
, and
Consequently, we have
As
we have
Similarly, as
Since a , c , 0 x and 0 y are positive, from (9) and (11), we can conclude that ( ) 0
, where T is a positive real number, from (9) and (11), we have
Since a and c are positive, we have
Consequently, both ( ) t x and ( ) t y are bounded and converge to the corresponding equilibrium values.
Hence, this control strategy can guarantee the asymptotical stability of the system, the monotonic decrement of the concentration of the HIV-1 viral load, as well as the satisfaction of the positivity constraint of the system states and that of the dose concentration.
Although this control strategy guarantees that the system states will converge to the equilibrium point, the convergent rate is slow because ( ) t V is independent of both ( ) 
where 1 k and 2 k are non-negative constants as well as 3 k is a positive constant. Obviously, the previous control strategy is a particular case of this control strategy. Now, we have
It can be checked easily that ( ) 0
. Similarly, from (9) and (11), we
Hence, the success of this control strategy highly depends whether ( ) 0
or not. However, in general it is not guaranteed that ( ) 0
is satisfied even though this control strategy could achieve a fast convergent rate because ( ) 
then we have
and
. Similarly, from (9) and (11), we have ( ) 0 
. Denote α as a positive constant. 
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The overall controlled system is asymptotically stable, the concentration of the HIV-1 viral load is monotonic decreasing, as well as the positivity constraint of the system states and that of the dose concentration is guaranteed to be satisfied.
Proof:
Since ( ) 0 by Case I is faster than that defined by Case II and Case III, α should be small so that the concentration of the HIV-1 viral load will decrease at a faster rate. However, as ( ) 0
, too small value of α would cause a rapid change of the state trajectory near the equilibrium point. Consequently, patients cannot stop the therapy. To obtain a balance between these two factors,
we choose α to be a value equal to 59.5140% of ( ) k are large and 3 k is small. As a fast response is preferred, there is a tradeoff between the strength of the side effects and the convergent rate of the system. To obtain a balance between these two factors, we propose to solve the problem via an optimization approach as follows:
For the control strategy defined by Case I, since (24) and ( ) 0
. This implies that the maximum value of ( ) 
Similarly, we define an acceptable bound on the rate of change of the concentration of the HIV-1 viral load and on the rate of change of ( ) Due to the tradeoff between the strength of the side effects and the convergent rate of the system, we formulate the following optimization problem as follows:
subject to (25)- (27) (28b) and 1 k , 2 k and 3 k are positive.
Problem P is a standard linear programming problem, many existing solvers, such as Matlab optimization toolbox, can be employed for solving the problem. Moreover, as this optimization problem is convex, the obtained solution will be globally optimal if the feasible set is nonempty. Figure 10 plots the controlled state responses with the system parameters and the initial condition being the same as those applied in Figure 1 , where α , 1 k , 2 k and 3 k are determined based on the above discussion. It can be seen from the figure that the concentration of the HIV-1 viral load is monotonic decreasing, the system states asymptotically converge to the equilibrium point, as well as the concentrations of the CD4 lymphocyte population, the CD8 lymphocyte population and the HIV-1 viral load are non-negative and bounded. Hence, the proposed control strategy satisfies the positivity constraint. Figure 11 shows the corresponding dose concentration. It can be seen from the figure that the maximum dose concentration within the first 4 weeks is 0.37, which satisfies the specification.
The dose concentration is monotonic decreasing within the first 4 weeks, but it drops dramatically to low values after the 4th week because the system switches from the control strategy defined by Case I to that defined by Case II. Between the 85.7th and 219.7th weeks, the dose concentration is exactly equal to zero. This implies that the system switches to the control strategy defined by Case III and no therapy is required. After the 219.7th week, the system switches back to the control strategy defined by Case II, so the dose concentration is non-zero and maintains at low level. To illustrate the effectiveness of the control strategy defined by Case I, Figure 12 plots the controlled state responses of the system switched only between Case II and Case III. Figure 13 plots the corresponding dose concentration with the system parameters and the initial condition being the same as those applied in Figure 1 . It can be seen from the figure that the concentration of the HIV-1 viral load decreases slowly while that based on the control strategy defined by Case I drops to the value equal to α quickly (at the 4th week).
V. CONCLUSIONS
In this paper, we suggest to initiate the therapy based on both the concentration of the HIV-1 viral load and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population. If the concentration of the HIV-1 viral load is higher than a threshold, then the first type of therapy will be applied. If the concentration of the HIV-1 viral load is lower than or equal to the threshold and the ratio of the CD4 lymphocyte population to the CD8 lymphocyte population is greater than another threshold, then the second type of therapy will be applied. Otherwise, no therapy will be applied. The advantages of the proposed control strategy are that the therapy can be stopped under certain conditions, while the state variables of the overall system is asymptotically stable with fast convergent rate, the concentration of the controlled HIV-1 viral load is monotonic decreasing, as well as the positivity constraint of the system states and that of the dose concentration is guaranteed to be satisfied.
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